Trials / Completed
CompletedNCT02918279
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity. 56-week, Double-blind, Randomised, Parallel-group, Placebo-controlled Multi-national Trial Followed by a 26-week Period Off Study-drug
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 251 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted globally. The aim of this trial is to investigate the effect of liraglutide for weight management in pubertal adolescent subjects with obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liraglutide | Administered once daily subcutaneously (s.c., under the skin) |
| DRUG | Placebo | Administered once daily subcutaneously (s.c., under the skin) |
Timeline
- Start date
- 2016-09-29
- Primary completion
- 2019-02-14
- Completion
- 2019-08-08
- First posted
- 2016-09-28
- Last updated
- 2020-04-27
- Results posted
- 2020-04-27
Locations
33 sites across 5 countries: United States, Belgium, Mexico, Russia, Sweden
Source: ClinicalTrials.gov record NCT02918279. Inclusion in this directory is not an endorsement.